After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology ...
Apr 7, 2023
1
72
Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.
Mar 13, 2023
0
2
Many vaccine trials use age de-escalation with the goal of safeguarding the interests of younger, more vulnerable populations. After a vaccine's safety and efficacy are established in adult populations, progressively younger ...
Feb 21, 2023
0
20
Interactive risk communication formats can be more effective than conventional text-based formats in overcoming vaccine hesitancy and building public trust. These are the findings of a study conducted by researchers at Charité-Universitätsmedizin ...
Feb 16, 2023
0
41
It has been more than 100 years since the first and only tuberculosis (TB) vaccine—the Bacillus Calmette–Guérin (BCG) vaccine—was used for the first time medically in 1921. With an estimated 1.6 million people dying ...
Feb 15, 2023
1
25
President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first ...
Jan 31, 2023
0
30
The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.
Jan 17, 2023
0
5
As a surge in cases of respiratory syncytial virus, or RSV, continues pushing hospitals to capacity across the U.S., researchers at Georgia State's Institute for Biomedical Sciences are working to develop vaccines and other ...
Jan 6, 2023
0
8
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40
A three-dose regimen of a whole-parasite vaccine against malaria—called Plasmodium falciparum sporozoite (PfSPZ) vaccine—demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which ...
Jan 4, 2023
0
71
